CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Pierrel Company Snapshot
Pierrel operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pierrel with three other pharmaceutical manufacturers in Europe: Photocure ASA of Norway (2017 sales of 150.91 million Norwegian Kroner [US$17.82 million] of which 57% was Hexvix/Cysview Own Sales), Science In Sport Plc of the United Kingdom (£15.62 million [US$19.89 million] of which 89% was Core), and Replek AD Skopje which is based in Macedonia (955.23 million Denar [US$17.70 million] ).

Sales Analysis. During the year ended December of 2017, sales at Pierrel were 16.84 million Euro (US$19.22 million). This is an increase of 18.0% versus 2016, when the company's sales were 14.27 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Pierrel
  Stock Performance Chart for Pierrel
 
  Stock Data: Recent Stock Performance:
  Current Price (8/17/2018): .16
(Figures in Euro)
1 Week -0.9%   13 Weeks -1.8%  
4 Weeks -16.4%   52 Weeks -24.2%  
 
Pierrel Key Data:
  Ticker: PRL Country: Italy
  Exchanges: ISE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 16,837,000
(Year Ending Jan 2018).
Employees: 305
  Currency: Euro Market Cap: 9,450,707
  Fiscal Yr Ends: December Shares Outstanding: 59,066,920
  Share Type: Aziohi Ordinaire Closely Held Shares: 30,718,024
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.